Evaluation of the Effectiveness of Additional Risk Minimization Measures for Voriconazole in the EU: Findings and Lessons Learned From a Healthcare Professional Survey
Pharmaceutical Medicine - United Kingdom
doi 10.1007/s40290-019-00273-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 1, 2019
Authors
Publisher
Springer Science and Business Media LLC